Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

SEB is cytotoxic and alters EC barrier function through protein tyrosine phosphorylation in vitro.

Campbell WN, Fitzpatrick M, Ding X, Jett M, Gemski P, Goldblum SE.

Am J Physiol. 1997 Jul;273(1 Pt 1):L31-9.

PMID:
9252537
2.

Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures.

Neill RJ, Jett M, Crane R, Wootres J, Welch C, Hoover D, Gemski P.

Infect Immun. 1996 Aug;64(8):3007-15.

3.

The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli.

Cross A, Asher L, Seguin M, Yuan L, Kelly N, Hammack C, Sadoff J, Gemski P Jr.

J Clin Invest. 1995 Aug;96(2):676-86.

4.

Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin.

Jett M, Neill R, Welch C, Boyle T, Bernton E, Hoover D, Lowell G, Hunt RE, Chatterjee S, Gemski P.

Infect Immun. 1994 Aug;62(8):3408-15.

5.

Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits.

Sjogren R, Neill R, Rachmilewitz D, Fritz D, Newland J, Sharpnack D, Colleton C, Fondacaro J, Gemski P, Boedeker E.

Gastroenterology. 1994 Feb;106(2):306-17.

PMID:
8299898
7.

Investigation of a staphylococcal food poisoning outbreak in a centralized school lunch program.

Richards MS, Rittman M, Gilbert TT, Opal SM, DeBuono BA, Neill RJ, Gemski P.

Public Health Rep. 1993 Nov-Dec;108(6):765-71.

8.

Choice of bacteria in animal models of sepsis.

Cross AS, Opal SM, Sadoff JC, Gemski P.

Infect Immun. 1993 Jul;61(7):2741-7. Review. No abstract available.

9.

The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.

Kim KS, Itabashi H, Gemski P, Sadoff J, Warren RL, Cross AS.

J Clin Invest. 1992 Sep;90(3):897-905.

12.
13.
14.

Rapid purification of staphylococcal enterotoxin B by high-pressure liquid chromatography.

Strickler MP, Neill RJ, Stone MJ, Hunt RE, Brinkley W, Gemski P.

J Clin Microbiol. 1989 May;27(5):1031-5.

15.

Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.

Neill RJ, Gemski P, Formal SB, Newland JW.

J Infect Dis. 1988 Oct;158(4):737-41.

PMID:
3049838
16.

Survey of purported virulence factors of Escherichia coli isolated from blood, urine and stool.

Opal SM, Cross A, Gemski P, Lyhte LW.

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):425-7.

PMID:
3137052
17.

Cloning and use of Vwa plasmid DNA as gene probes for virulent Yersiniae.

Gemski P, Sodd MA, Neill RJ, Seguin MC, Williams JE.

Contrib Microbiol Immunol. 1987;9:296-303. No abstract available.

PMID:
3665509
18.

Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli.

Cross AS, Kim KS, Wright DC, Sadoff JC, Gemski P.

J Infect Dis. 1986 Sep;154(3):497-503.

PMID:
3525697
19.

Genetic studies of kanamycin resistance in Campylobacter jejuni.

Kotarski SF, Merriwether TL, Tkalcevic GT, Gemski P.

Antimicrob Agents Chemother. 1986 Aug;30(2):225-30.

20.

High frequency transduction by phage hybrids between coliphage phi 80 and Salmonella phage P22.

Yamamoto N, Droffner ML, Yamamoto S, Gemski P, Baron LS.

J Gen Virol. 1985 Aug;66 ( Pt 8):1661-8.

PMID:
3894574
21.

Heterogeneity of lipid A: comparison of lipid A types from different gram-negative bacteria.

Mattsby-Baltzer I, Gemski P, Alving CR.

J Bacteriol. 1984 Sep;159(3):900-4.

22.

Identification of Escherichia coli K1 antigen.

Cross A, Orskov I, Orskov F, Sadoff J, Gemski P.

J Clin Microbiol. 1984 Aug;20(2):302-4.

23.

Heterogeneity of lipid A.

Mattsby-Baltzer I, Gemski P, Alving CR.

Rev Infect Dis. 1984 Jul-Aug;6(4):444-8.

PMID:
6474004
24.

Genetic methods for the detection of microbial pathogens. Identification of enterotoxigenic Escherichia coli by DNA colony hybridization: collaborative study.

Hill WE, Payne WL, Crouch RJ, Davis VM, English LL, Ferreira JL, Gemski P, Jagow JA, Moseley SL, Noah CW, et al.

J Assoc Off Anal Chem. 1984 Jul-Aug;67(4):801-7.

PMID:
6381467
25.

The importance of the K1 capsule in invasive infections caused by Escherichia coli.

Cross AS, Gemski P, Sadoff JC, Orskov F, Orskov I.

J Infect Dis. 1984 Feb;149(2):184-93.

PMID:
6199436
26.

Structural studies of the Escherichia coli O-antigen 25.

Kenne L, Lindberg B, Madden JK, Lindberg AA, Gemski P Jr.

Carbohydr Res. 1983 Oct 28;122(2):249-56.

PMID:
6200224
27.

Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.

Griffin DE, Gemski P.

Infect Immun. 1983 Apr;40(1):425-8.

28.

Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States.

Kay BA, Wachsmuth K, Gemski P, Feeley JC, Quan TJ, Brenner DJ.

J Clin Microbiol. 1983 Jan;17(1):128-38.

29.

Genetic studies of hybrids between coliphage phi 80 and Salmonella phage P22.

Yamamoto N, Gemski P, Baron LS.

J Gen Virol. 1983 Jan;64 (Pt 1):199-205.

PMID:
6822815
30.

Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.

Cross AS, Zollinger W, Mandrell R, Gemski P, Sadoff J.

J Infect Dis. 1983 Jan;147(1):68-76.

PMID:
6401788
31.

K antigen and serum sensitivity of rough Escherichia coli.

Opal S, Cross A, Gemski P.

Infect Immun. 1982 Sep;37(3):956-60.

32.

New virulence-associated plasmid in Yersinia enterocolitica.

Kay BA, Wachsmuth K, Gemski P.

J Clin Microbiol. 1982 Jun;15(6):1161-3.

33.

Role of antigen form in development of mucosal immunoglobin A response to Shigella flexneri Antigens.

Keren DF, Collins HH, Gemski P, Holt PS, Formal SB.

Infect Immun. 1981 Mar;31(3):1193-202.

34.

Isolation and characterization of minicell-producing mutants of Shigella spp.

Gemski P, Griffin DE.

Infect Immun. 1980 Oct;30(1):297-302.

35.
36.

Presence of a virulence-associated plasmid in Yersinia pseudotuberculosis.

Gemski P, Lazere JR, Casey T, Wohlhieter JA.

Infect Immun. 1980 Jun;28(3):1044-7.

37.
38.

Shigellosis and Escherichia coli diarrhea: relative importance of invasive and toxigenic mechanisms.

O'Brien AD, Gentry MK, Thompson MR, Doctor BP, Gemski P, Formal SB.

Am J Clin Nutr. 1979 Jan;32(1):229-33. Review.

PMID:
104615
39.

lambdaimm P22dis: a hybrid of coliphage lambda with both immunity regions of Salmonella phage P22.

Yamamoto N, Wohlhieter JA, Gemski P, Baron LS.

Mol Gen Genet. 1978 Nov 9;166(3):233-43.

PMID:
368575
40.

Invasive Escherichia coli.

Formal SB, O'Brien A, Gemski P, Doctor BP.

J Am Vet Med Assoc. 1978 Sep 1;173(5 Pt 2):596-8. Review. No abstract available.

PMID:
359519
41.

Interaction between bacteriophage Sf6 and Shigella flexner.

Lindberg AA, Wollin R, Gemski P, Wohlhieter JA.

J Virol. 1978 Jul;27(1):38-44.

42.

The role of Peyer's patches in the local immune response of rabbit ileum to live bacteria.

Keren DF, Holt PS, Collins HH, Gemski P, Formal SB.

J Immunol. 1978 Jun;120(6):1892-6. No abstract available.

PMID:
351061
43.

Cellular release of heat-labile enterotoxin of Escherichia coli by bacteriophage induction.

Gemski P, O'Brien AD, Wohlhieter JA.

Infect Immun. 1978 Mar;19(3):1076-82.

44.

Genetic studies of hybrids between coliphage lambda and salmonella phage P22: genetic analysis of the P22-lambda hybrid class.

Yamamoto N, Ushijima N, Gemski P, Baron LS.

Mol Gen Genet. 1977 Oct 20;155(2):117-21.

PMID:
337122
45.

Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri.

Levine MM, Woodward WE, Formal SB, Gemski P Jr, DuPont HL, Hornick RB, Snyder MJ.

J Infect Dis. 1977 Oct;136(4):577-82.

PMID:
333041
46.

Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin.

O'Brien AD, Thompson MR, Gemski P, Doctor BP, Formal SB.

Infect Immun. 1977 Mar;15(3):796-8.

47.

Bacterial enterocolitis.

Formal SB, Gemski P Jr.

Monogr Pathol. 1977;(18):31-5. No abstract available.

PMID:
347258
48.

Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin.

Thompson MR, Steinberg MS, Gemski P, Formal SB, Doctor BP.

Biochem Biophys Res Commun. 1976 Aug 9;71(3):783-8. No abstract available.

PMID:
786292
49.

Studies on the pathogenesis of intestinal disease caused by invasive bacteria [proceedings].

Formal SB, Gemski P Jr.

Zentralbl Bakteriol Orig A. 1976 Aug;235(1-3):9-12. No abstract available.

PMID:
983528
50.

Studies on the pathogenesis of enteric infections caused by invasive bacteria.

Formal SB, Gemski P Jr, Giannella RA, Takeuchi A.

Ciba Found Symp. 1976;(42):27-43. Review.

PMID:
62646

Supplemental Content

Loading ...
Support Center